The Sarks Macular Degeneration Research Foundation

Low

Corporate Foundation|ABN 31100584748ACNC Register →

Compare with Snow Compare with PRF Compare with Minderoo Compare with Ian Potter Compare with ECSTRA Open compare surface

Annual Giving

$500K

Grant Range

$10K – $5.0M

Tips for Applicants

Given its specific research focus and lack of a public website, potential applicants should develop highly targeted proposals for macular degeneration research. Direct outreach to the foundation, if contact information can be found, may be necessary.

Giving Philosophy

As a corporate foundation, The Sarks Macular Degeneration Research Foundation is committed to advancing scientific understanding and treatment of macular degeneration. It likely prioritises funding innovative and impactful research projects that aim to improve outcomes for those affected by the condition, focusing on initiatives within New South Wales.

ACNC Financial History

Year	Grants Given	Revenue	Total Assets	Net Assets
FY2022	—	$6.0M	$6.0M	$6.0M
1yr total	Unknown	Source: ACNC Annual Information Statements

Focus Areas

health

Geographic

AU-NSW

Recipients

communityaged

Financial Details

Source of Wealth

The foundation's wealth originates from a corporate entity, indicating a commitment to corporate social responsibility or a specific philanthropic interest tied to the corporation's activities or founders.